Company Filing History:
Years Active: 1977-1978
Title: The Innovative Contributions of Norman Adler
Introduction
Norman Adler is a notable inventor based in Arlington, MA, who has made significant contributions to the field of medical diagnostics. With a total of three patents to his name, Adler's work primarily focuses on the development of radionuclide diagnostic agents and complex compounds that enhance imaging techniques in medicine.
Latest Patents
Adler's latest patents include a bone-seeking technetium-99m complex. This complex features a technetium-99m-stannous-phosphate formulation, where the phosphate moiety includes pyrophosphate. Notably, it contains a specific percentage of linear polyphosphate, which is crucial for its effectiveness. The patent outlines a method for in vivo intravenous administration of this sterile, nonpyrogenic complex, followed by radioassay scanning or imaging of skeletal structures. Another significant patent involves radionuclide diagnostic agents that comprise technetium-99m, a reducing agent, and various polyhydroxycarboxylic acids. These agents are particularly useful in studying kidney morphology and diagnosing ischemic or diseased tissues.
Career Highlights
Norman Adler has been associated with New England Nuclear Corporation, where he has applied his expertise in developing innovative diagnostic solutions. His work has contributed to advancements in medical imaging and diagnostics, making a lasting impact on the healthcare industry.
Collaborations
Adler has collaborated with notable colleagues, including Leopoldo Lazaro Camin and Paul Gold. Their combined efforts have furthered research and development in the field of radionuclide diagnostics.
Conclusion
Norman Adler's contributions to medical diagnostics through his innovative patents and collaborations have significantly advanced the field. His work continues to influence the development of effective diagnostic agents and imaging techniques.